Ledger.Open graph →
SEC Form D · filed April 23, 2010

ReVision Therapeutics, Inc

Offering
$5.0M
Sold
$2.3M
Exemption
—
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

People & firms on this filing (8)

Kevin Kinsella · San Diego, CADirectorNathan Mata · San Diego, CAExecDouglas Downs · San Diego, CAExecJay Lichter, Ph.D · San Diego, CAExec · DirectorCheyenne Crow · MCLEAN, VAExec · DirectorRobert Doornick · MCLEAN, VAExecWilliam Heath · MCLEAN, VAExecJohn Betts · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗